0% found this document useful (0 votes)
6 views2 pages

Hamdan Salim-349438

Uploaded by

neljojosephasp
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
6 views2 pages

Hamdan Salim-349438

Uploaded by

neljojosephasp
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

Patient Name : Hamdan Salim-349438 Referral : SELF

Age / Gender : 32 years / Male Collection Time : Jan 01, 2022, 05:00 p.m.
Bill ID : 41387 Reporting Time : Jan 01, 2022, 09:30 p.m.
Patient ID/SRF ID : 3400/EKM/202201170 Sample ID :

Source : Sunrise Institute of Medical Science Pvt Ltd


KC101220169
Passport No : U0735182

COVID-19 Detection by RT-PCR.


Aim:
To screen the patient samples for the detection of SARS-CoV-2.
Sample type :
Oropharyngeal And Nasopharyngeal Swab

ICMR Registration No: RIVLAPLKK


Results:

Target Results

N gene Not Detected

ORF_1ab Not Detected

SARS-CoV-2 RNA Not Detected

Final Report Negative

Test methodology:
The test is intended to detect the presence of SARS-CoV-2 in the patient sample. This test utilises a qualitative
multiplexed Taqman based real-time PCR for amplification of specific regions of the genome of the pathogen viz.
ORF_1ab and N gene while RNase P gene serves as an internal positive control. These genes were amplified & detected
as per manufacturer’s instructions.
Technical note:
Although all precautions are taken, the technical error rate of all types of DNA analysis is approximately 2%. It is important that all clinicians or persons requesting DNA

diagnostic tests are aware of this before acting upon these results.

Clinical significance:
Coronavirus disease-2019 (COVID-19) is an infectious disease caused by a novel coronavirus, Severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). Most people infected with the COVID-19 virus experience mild to moderate
respiratory illness and recover without requiring special treatment. Individuals with advanced age and those with
underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are at high
risk to develop serious illness.
Disclaimers:
1. It is assumed that the sample received in the laboratory, belongs to the same patient as mentioned in the TRF.
2. This kit is IVD approved, and its performance characteristics have been assessed as per CAP and NABL

Page 1 of 2
Patient Name : Hamdan Salim-349438 Referral : SELF
Age / Gender : 32 years / Male Collection Time : Jan 01, 2022, 05:00 p.m.
Bill ID : 41387 Reporting Time : Jan 01, 2022, 09:30 p.m.
Patient ID/SRF ID : 3400/EKM/202201170 Sample ID :

Source : Sunrise Institute of Medical Science Pvt Ltd


KC101220169
Passport No : U0735182

guidelines.
3. Interpretation of the results have been performed to the best knowledge of the laboratory based on the
information available at the time of reporting.
4. A negative result does not rule out the possibility of an infection and should not be used as the sole basis for
patient management decisions. Negative results must be combined with clinical observations, patient history, and
epidemiological information.
5. The report shall be generated within stipulated turnaround time (TAT). However, in the view of complexity of the
test the TAT may vary. The lab under no circumstances will be liable for any delay beyond the mentioned TAT.
6. We would like to state that the report(s) generated from the tests do not provide any diagnosis or opinion, neither
do they recommend any cure in any manner. The laboratory hereby recommends that the patients should take
assistance of the prescribing clinician or the certified physician/doctor to interpret the report(s) generated.
7. The test results should be carefully correlated considering the present clinical condition of the patient and other
relevant findings if any related to the patient.
8. This report cannot be used for any medico-legal purpose.
9. A detected result does not distinguish between a viable/ replicating organism and a non-viable organism.
10. Conflicting results may arise due to inappropriate specimen and contamination during specimen collection.
11. Sensitivity of the test would be influenced by the quality of the sample submitted and the stage of the infection.
References:
1. Centers for Disease Control and Prevention. 2019 Novel coronavirus, Wuhan, China. Information for Healthcare Professionals.

https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html.

2. World Health Organization. Novel Coronavirus (2019-nCoV) technical guidance. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance.

3. ICMR circular for CT (cycle threshold) value for RTPCR test for COVID-19; D.O.No. V lN 412021 IECD-I; Dated: 5th April202l

**END OF REPORT**

Page 2 of 2

You might also like